The North America extremity tissue expanders market size was valued at over USD 60.9 million in 2017 and is anticipated to exhibit a CAGR of 3.4% over the forecast period. Growing number of trauma-related injuries and severe road accident cases is considered to be one of the most significant drivers leading to product demand.
According to the U.S. Fire Administration (USFA), in 2015, around 15,700 people suffered from burns in U.S. Accidents can lead to severe injuries of upper and lower extremities as well as scars and deformities. This often results in reconstructive surgeries, which make use of tissue expanders.
Increase in incidence of congenital deformity or birth defects has also led to high growth of the market. Congenital anomalies or any type of birth defects involving upper and lower extremities may require tissue expander-based reconstruction procedures.
Technological advancements, growing awareness about tissue expanders, improvements in quality of patient care, and rise in healthcare expenditure are some of the major factors that can be attributed to the increase in adoption of tissue expander-based surgical treatments. Some advantages of these products are a near-perfect match of texture and color, high rate of successful tissue grafting, and minimum scarring.
On the basis of shape, round-shaped expanders held a significant share of the revenue in 2017. This is due to the fact that these products are round, soft, and accurately proportioned. The round shape makes them ideal for knee and elbow reconstruction procedures.
Crescent-shaped extremity tissue expanders also generated significant revenue in the market. This can be attributed to the fact that these expanders are available in both smooth and textured surfaces. Sientra, Inc. and KOKEN CO., LTD. have a massive portfolio of these products.
Rectangular-shaped expanders are most commonly used for the reconstruction of arms and legs. These products are available as both silicone and saline-filled expanders. KOKEN CO., LTD. has a significant portfolio of these variants and is a well-known developer of medical plastic products.
On the basis of end-use, hospitals generated the maximum revenue in the North America extremity tissue expanders market in 2017. This is due to the fact that most surgeries are performed at hospitals. Hospitals allow patients to choose from a wide range of surgical options for improving their physical appearance.
Burn centers also held significant market share in 2017 owing to rising number of burn-related injuries in the North American region. In case of serious injuries, extremity tissue expanders are used to improve functioning of the affected part and enhance cosmetic appearance.
Other end-use settings include cosmetology clinics, which provide services for enhancing physical appearance of the target population. A patient typically consults a cosmetologist before undergoing a surgical procedure that enhances physical appearance. Cosmetologists offer specialized services and allow patients to assess various available alternatives for reconstructive surgeries.
In 2017, the U.S. dominated the market in terms of revenue due to presence of well-established healthcare infrastructure, growing healthcare spending, and widespread prevalence of various congenital disorders. According to the Centers for Disease Control and Prevention (CDC), 1 in every 33 babies born in U.S. is affected by a birth defect. In addition, rise in number of reconstructive surgeries in the country has led to high demand for these products.
In Canada, the market is expected to grow at a lucrative rate over the forecast period, emerging as the fastest growing regional segment. Increase in number of road accidents and trauma injuries has led to a rise in demand for these expanders in leg and arm reconstruction procedures, which is expected to drive the market.
Some of the key players of the market are Mentor Worldwide LLC; PMT Corporation; Allergan; Sientra, Inc.; and KOKEN CO., LTD. These companies are continuously focusing on initiatives such as mergers and acquisitions, regional expansion, and novel product development. For instance, in 2015, Allergan plc acquired Legacy Allergan, a specialty pharmaceutical company specializing in neurosciences, ophthalmology, and esthetics/medical/plastic surgery/dermatology, with an aim to expand its product portfolio.
Attribute |
Details |
Base year for estimation |
2017 |
Actual estimates/Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Market representation |
Revenue in USD Million & CAGR from 2018 to 2025 |
Regional scope |
North America |
Country scope |
U.S., Canada |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at regional and country levels and provides an analysis on latest industry trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the North America extremity tissue expanders market report on the basis of shape, end use, and country:
Shape Outlook (Revenue, USD Million, 2014 - 2025)
Anatomical
Round
Rectangular
Crescent
Others
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Hospitals
Pediatric
Others
Burn Centers
Others
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.